Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huaping Dai

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
Respiratory Research|May 14, 2026
Quantitative label-free multiphoton imaging of collagen features predicts disease severity and progression in idiopathic pulmonary fibrosisWei Liu, Yu Sun, Ling Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Pulmonary alveolar type I cell population consists of two distinct subtypes that differ in cell fateYanjie Wang, Zan Tang, Huanwei Huang, et al.
Journal of Cellular and Molecular Medicine|October 29, 2022
IL-17A promotes lung fibrosis through impairing mitochondrial homeostasis in type II alveolar epithelial cellsHuijuan Xiao, Liang Peng, Dingyuan Jiang, et al.
The Lancet. Respiratory Medicine|November 24, 2023
3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort studyHui Zhang, Chaolin Huang, Xiaoying Gu, et al.
Stem Cell Research & Therapy|April 13, 2022
Every road leads to Rome: therapeutic effect and mechanism of the extracellular vesicles of human embryonic stem cell-derived immune and matrix regulatory cells administered to mouse models of pulmonary fibrosis through different routesShengnan Yang, Peipei Liu, Tingting Gao, et al.
BMC Pulmonary Medicine|March 15, 2025
Evaluation of respiratory muscle dysfunction in patients with idiopathic pulmonary fibrosis: a prospective observational study with magnetic resonance imagingXiaoyan Yang, Hongyi Wang, Anqi Liu, et al.
International Journal of General Medicine|August 27, 2025
Quantitative Imaging Markers on HRCT Predict Rapid Progression and Adverse Events of Patients with Idiopathic Inflammatory Myopathies-Related Interstitial Lung DiseaseHongyi Wang, Yuhui Qiang, Jianping Wang, et al.
Chest|September 11, 2009
Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trialChen Wang, Zhenguo Zhai, Yuanhua Yang, et al.
Respiratory Research|December 31, 2009
Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trialChen Wang, Zhenguo Zhai, Yuanhua Yang, et al.
Frontiers in Medicine|August 19, 2022
The associations of radiological features of high-resolution computed tomography with the outcomes of transbronchial cryobiopsy in interstitial lung diseases: A cohort studyGuowu Zhou, Yanhong Ren, Jun Li, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Respiratory Research|May 14, 2026
Quantitative label-free multiphoton imaging of collagen features predicts disease severity and progression in idiopathic pulmonary fibrosisWei Liu, Yu Sun, Ling Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Pulmonary alveolar type I cell population consists of two distinct subtypes that differ in cell fateYanjie Wang, Zan Tang, Huanwei Huang, et al.
Journal of Cellular and Molecular Medicine|October 29, 2022
IL-17A promotes lung fibrosis through impairing mitochondrial homeostasis in type II alveolar epithelial cellsHuijuan Xiao, Liang Peng, Dingyuan Jiang, et al.
The Lancet. Respiratory Medicine|November 24, 2023
3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort studyHui Zhang, Chaolin Huang, Xiaoying Gu, et al.
Stem Cell Research & Therapy|April 13, 2022
Every road leads to Rome: therapeutic effect and mechanism of the extracellular vesicles of human embryonic stem cell-derived immune and matrix regulatory cells administered to mouse models of pulmonary fibrosis through different routesShengnan Yang, Peipei Liu, Tingting Gao, et al.
BMC Pulmonary Medicine|March 15, 2025
Evaluation of respiratory muscle dysfunction in patients with idiopathic pulmonary fibrosis: a prospective observational study with magnetic resonance imagingXiaoyan Yang, Hongyi Wang, Anqi Liu, et al.
International Journal of General Medicine|August 27, 2025
Quantitative Imaging Markers on HRCT Predict Rapid Progression and Adverse Events of Patients with Idiopathic Inflammatory Myopathies-Related Interstitial Lung DiseaseHongyi Wang, Yuhui Qiang, Jianping Wang, et al.
Chest|September 11, 2009
Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trialChen Wang, Zhenguo Zhai, Yuanhua Yang, et al.
Respiratory Research|December 31, 2009
Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trialChen Wang, Zhenguo Zhai, Yuanhua Yang, et al.
Frontiers in Medicine|August 19, 2022
The associations of radiological features of high-resolution computed tomography with the outcomes of transbronchial cryobiopsy in interstitial lung diseases: A cohort studyGuowu Zhou, Yanhong Ren, Jun Li, et al.
Pageof 18